Persistent SARS-CoV-2-specific immune defects in kidney transplant recipients following third mRNA vaccine dose [0.03%]
肾脏移植受者接种第三剂mRNA疫苗后的SARS-CoV-2特异性免疫缺陷仍然存在
William A Werbel,Andrew H Karaba,Teresa Po-Yu Chiang et al.
William A Werbel et al.
Kidney transplant recipients (KTRs) show poorer response to SARS-CoV-2 mRNA vaccination, yet response patterns and mechanistic drivers following third doses are ill-defined. We administered third monovalent mRNA vaccines to n = 81 KTRs with...
An experiment on the impact of predictive analytics on kidney offers acceptance decisions [0.03%]
预测分析对肾脏移植接受决策影响的实验研究
Ian McCulloh,Darren Stewart,Kevin Kiernan et al.
Ian McCulloh et al.
Because of the breadth of factors that might affect kidney transplant decisions to accept an organ or wait for another, presumably "better" offer, a high degree of heterogeneity in decision making exists among transplant surgeons and hospit...
Stakeholders' perspectives on transplant metrics: the 2022 Scientific Registry of Transplant Recipients' consensus conference [0.03%]
移植指标的利害关系人视角：2022年移植受者科学登记处共识会议
Jon J Snyder,Cory R Schaffhausen,Allyson Hart et al.
Jon J Snyder et al.
In July 2022, the Scientific Registry of Transplant Recipients (SRTR) hosted an innovative, multistakeholder consensus conference to identify information and metrics desired by stakeholders in the transplantation system, including patients,...
Robert J Stratta
Robert J Stratta
The effectiveness and safety of antibody induction immunosuppression in a large cohort of United States pediatric liver transplant recipients [0.03%]
抗体诱导免疫抑制在美國兒科肝移植受者的有效性和安全性的大型隊列研究
Phoebe Wood,Yuan-Shung Huang,Lucia Sanchez et al.
Phoebe Wood et al.
Data on the potential benefits and risks of induction therapy in pediatric liver transplantation (LT) are limited. This was a retrospective cohort study of 2748 pediatric LT recipients at 26 children's hospitals between January 1, 2006 to M...
Corrigendum to 'Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report' [American Journal of Transplantation 23 (2023) 133-149] [0.03%]
“移植中的致敏：评估风险2022工作组会议报告”一文的勘误(第23卷(2023年)133-149页)
Anat R Tambur,Oriol Bestard,Patricia Campbell et al.
Anat R Tambur et al.
Pilot test of a multicomponent implementation strategy for equity in advanced heart failure allocation [0.03%]
先进心力衰竭分配公平性的多组件实施策略试点试验
Khadijah Breathett,Ryan H Yee,Natalie Pool et al.
Khadijah Breathett et al.
Advanced heart failure (AHF) therapy allocation is vulnerable to bias related to subjective assessments and poor group dynamics. Our objective was to determine whether an implementation strategy for AHF team members could feasibly contribut...
Corrigendum to "Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression" [American Journal of Transplantation (2022) 2571-2585] [0.03%]
“表达PD-L1和IDO融合蛋白的胰岛移植物在无需全身免疫抑制的情况下避开免疫排斥并逆转免疫competent小鼠的糖尿病”一文的勘误注释[《美国移植杂志》（2022）2571-2585]
Pradyut K Paul,Rahul Das,Travis Drow et al.
Pradyut K Paul et al.
Impact of expanding HOPE Act experience criteria on program eligibility for transplantation from donors with human immunodeficiency virus to recipients with human immunodeficiency virus [0.03%]
扩大HOPE法案适应范围对人类免疫缺陷病毒供者向人类免疫缺陷病毒接受者进行移植的计划资格的影响
Mary G Bowring,Jessica M Ruck,Mitchell G Bryski et al.
Mary G Bowring et al.
Fernando Caravaca-Fontán,Laura Ibarra,José Luis Rodríguez-Peralto et al.
Fernando Caravaca-Fontán et al.